A LIGAND EPITOPE INVITRO ANALYSIS OF MAJOR HISTOCOMPATIBILITY DETERMINANTS EXPRESSED ON LYMPHOCYTE-B AND LYMPHOCYTE-T

被引:0
|
作者
FERNANDEZ, N
KURPISZ, M
LABETA, M
SACHS, J
PAWELEC, G
机构
[1] POLISH ACAD SCI,INST HUMAN GENET,PL-60479 POZNAN,POLAND
[2] MED KLIN TUBINGEN,IMMUNOL LAB,TUBINGEN,GERMANY
[3] UNIV LONDON LONDON HOSP,COLL MED,SCH MED,DEPT IMMUNOL,LONDON E1 2AD,ENGLAND
[4] UNIV HOSP BASEL,DEPT RES,CH-4031 BASEL,SWITZERLAND
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human histocompatibility leucocyte antigen (HLA)-specific monoclonal antibody probes were used to determine the affinity constant, and cell-surface density of HLA class I and class II determinants. The measurements were estimated for single-cell units of B-lymphoblastoid cell line (B-LCL) and cloned activated T cells in different functional states. Each HLA subset showed unimodal affinity constant values for the interaction with the corresponding HLA-specific antibodies. Such values ranged between 2-2 x 10(7) M-1 (class I) and 4.0 x 10(7) M-1 (class II) for different histocompatibility epitopes. In both B and T cells there was a rank order of epitope expression, class I being highly expressed (5 x 106 epitopes/cell) followed by DR, DQ and DP, (1.1-3.0 x 10(6) epitopes/cell). Suppressive clones carrying functionally defined stimulating determinants previously designated 'DY' carried similar numbers of DR, DQ and DP binding sites to DY- non-suppressive clones, but showed selective increases of class II determinants reactive with broad class II-specific antibodies. The results are discussed in the context of the functional consequences of different patterns of HLA epitope expression in immune responses.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 50 条
  • [31] ROSETTE FORMATION BY LYMPHOCYTE-T AND LYMPHOCYTE-B OF CAMEL
    KAURA, YK
    SRIVASTAVA, RN
    GROVER, YP
    PRASAD, S
    INDIAN JOURNAL OF ANIMAL SCIENCES, 1988, 58 (05): : 529 - 531
  • [32] CHANGES IN LYMPHOCYTE-T AND LYMPHOCYTE-B IN PATIENTS WITH LYMPHOGRANULOMATOSIS
    ILIN, NV
    VINOKUROVA, NA
    GERSHANOVICH, ML
    LETSKY, VB
    VOPROSY ONKOLOGII, 1979, 25 (06) : 19 - 22
  • [33] DETERMINATION OF LYMPHOCYTE-B AND LYMPHOCYTE-T IN CATTLE AND SWINE
    MULLER, G
    ARCHIV FUR EXPERIMENTELLE VETERINARMEDIZIN, 1984, 38 (04): : 555 - 564
  • [34] ACTIVATION OF LYMPHOCYTE-T AND LYMPHOCYTE-B IN NZB MICE
    COHEN, PL
    UGAI, K
    LIGLER, FS
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1982, 9 (03) : 199 - 205
  • [35] COMPARATIVE EFFECTS OF INVITRO EXPOSURE TO NONIONIZING RADIATION ON VIABILITY OF LYMPHOCYTE-T AND LYMPHOCYTE-B
    PARRISH, JA
    MORISON, WL
    CLINICAL RESEARCH, 1979, 27 (02): : A534 - A534
  • [36] SELECTIVE PARTIAL IGM DEFICIENCY - FUNCTIONAL ASSESSMENT OF LYMPHOCYTE-T AND LYMPHOCYTE-B INVITRO
    INOUE, T
    OKUMURA, Y
    SHIRAHAMA, M
    ISHIBASHI, H
    KASHIWAGI, S
    OKUBO, H
    JOURNAL OF CLINICAL IMMUNOLOGY, 1986, 6 (02) : 130 - 135
  • [37] THE PERIARTERIOLAR LYMPHOCYTE SHEATH IN IMMUNODEFICIENCY LYMPHOCYTE-T OR LYMPHOCYTE-B AREA
    VANHOUTE, AJ
    SCHUURMAN, HJ
    HUBER, J
    VANDERMEER, J
    VANDERVEGT, JH
    KUIS, W
    JAMBROES, G
    DEWEGER, RA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (03) : 318 - 322
  • [38] LYMPHOCYTE-B, LYMPHOCYTE-T, LYMPHOCYTE-NULL IN HUMAN DISEASE
    JIBRIL, AO
    VOLINI, FI
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1978, 8 (04): : 347 - 348
  • [39] IDENTICAL FORMS OF THE CD2 ANTIGEN EXPRESSED BY MOUSE LYMPHOCYTE-T AND LYMPHOCYTE-B
    ALTEVOGT, P
    MICHAELIS, M
    KYEWSKI, B
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (08) : 1509 - 1512
  • [40] ACTIVITY OF LYMPHOCYTE-T AND LYMPHOCYTE-B IN GENERAL PURULENT INFECTION
    MALAFEEVA, EV
    ROMANOV, VA
    BELOKUROV, YN
    GRAMENITSKY, AB
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1981, (04): : 39 - 42